开始
Carr

$ACAD chart update post-$BIIB

做多
ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD)  
Carr  
NASDAQ:ACAD   ACADIA Pharmaceuticals Inc.
1
0
The $BIIB buyout story has put a bid under other key biotech buyout targets like $ACAD. Chart shows a steady accumulation within a bullish channel in a modest uptrend.

相关观点

Carr
$NVAX breakout
Carr
$ACHN pop higher
免责声明

这些信息和出版物并不意味着也不构成TradingView提供或认可的金融、投资、交易或其它类型的建议或背书。请在使用条款阅读更多信息。